kislayt/lyme-tweet-classification-v0-llama-2-7b

TEXT GENERATIONConcurrency Cost:1Model Size:7BQuant:FP8Ctx Length:4kLicense:apache-2.0Architecture:Transformer Open Weights Cold

The kislayt/lyme-tweet-classification-v0-llama-2-7b is a 7 billion parameter Llama 2 model developed by kislayt, fine-tuned for the specific task of classifying tweets related to Lyme disease. This model leverages the Llama 2 architecture with a 4096-token context length to analyze and categorize social media content. Its primary differentiation lies in its specialized focus on medical text classification, particularly for Lyme disease, making it suitable for targeted information extraction and sentiment analysis in this domain.

Loading preview...

Model Overview

The kislayt/lyme-tweet-classification-v0-llama-2-7b is a specialized language model built upon the Llama 2 architecture, featuring 7 billion parameters and a context length of 4096 tokens. Developed by kislayt, this model is specifically fine-tuned for the classification of tweets related to Lyme disease.

Key Capabilities

  • Lyme Disease Tweet Classification: The model's core capability is to accurately identify and categorize social media posts (tweets) that discuss Lyme disease.
  • Specialized Medical Text Analysis: It is designed to understand and process language specific to medical topics, particularly within the context of Lyme disease.
  • Llama 2 Foundation: Benefits from the robust and widely-used Llama 2 base model, providing a strong foundation for natural language understanding.

Good For

  • Public Health Monitoring: Ideal for researchers or organizations tracking public discourse, sentiment, or information spread regarding Lyme disease on social media platforms.
  • Medical Information Extraction: Useful for identifying relevant tweets for further analysis in medical research or epidemiological studies related to Lyme disease.
  • Social Media Content Filtering: Can be employed to filter or categorize large volumes of tweets to isolate those pertinent to Lyme disease.